Reeling from the deaths of two patients who took Duchenne muscular dystrophy gene therapy Elevidys, Sarepta is launching a ...

Kennedy Jr. has downplayed the effectiveness of the long-used vaccine and instead promoted the development of new treatments ...

The United Kingdom is establishing a new biosecurity center designed to improve research into potentially pandemic-causing ...

Abbott is doubling down on the structural heart space, as it aims to gain ground in valve replacements following the recent ...

BioNTech is losing its chief strategy officer, with Ryan Richardson set to leave the company at the end of September to ...

Intuitive Surgical is showing off the remote capability of its robots, with a transatlantic demonstration hosted by the Society of Robotic Surgery conference being held this week in Stras | The ...

To secure the antibody, I-Mab is paying $1.8 million upfront to buy Bridge Health, to be followed by noncontingent quarterly ...

Patients with a mysterious eye pain disease may be one step closer to seeing the first approved treatment for their condition ...

Momentum in Johnson & Johnson’s cardiovascular business continues while the company looks to regain its footing in the ...

Novartis has ended work on ianalumab in a painful skin condition after the monoclonal antibody failed to meet “predefined ...

Alphabet spinoff SandboxAQ is teaming up with iOncologi to build a new mRNA vaccine for a common and aggressive brain tumor ...

Otsuka Pharmaceutical is putting down $33 million cash for a Swedish biotech’s IL1RAP antibodies designed to treat autoimmune ...